Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1021 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-31

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is implemented to identify factors having an impact on improvement or exacerbation of non-motor symptoms, to provide information contributing to development of medical care in this field and improvement of patients' QOL, and to clarify the association between the use of istradefylline and non-motor symptoms or QOL.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease

NCT06212089

Parkinson Disease

COMPLETED PHASE2

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

NCT00250393

Parkinson's Disease

COMPLETED PHASE2

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

NCT02610231

Idiopathic Parkinson's Disease

COMPLETED PHASE3

A Study of KW-6356 in Subjects With Early Parkinson's Disease

NCT02939391

Parkinson's Disease

COMPLETED PHASE2

An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease

NCT05916157

Parkinson's Disease (PD)

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Parkinson Disease

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have wearing off under treatment with levodopa-containing drugs administered at least three times daily
* Patients who have at least one non-motor symptom as a complication
* Patients at least 20 years of age at the time of consent
* Patients who have given written consent
* Patients who are receiving outpatient care

Exclusion Criteria

* Patients with dementia or a score of 23 or less on the Mini-Mental State Examination (MMSE)
* Patients, in the opinion of the investigator or subinvestigator, having conditions impairing the proper assessment of the MDS-UPDRS or PDQ-8 (e.g., patients who are receiving treatment for malignant tumor)

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No